Askpot
← Company directory

Accelerator™ Drug Development: SWOT analysis

Accelerator™ Drug Development is a comprehensive service offered by Thermo Fisher Scientific that supports pharmaceutical and biotech companies in bringing treatments to market faster. It combines contract development and manufacturing organization (CDMO) and clinical research organization (CRO) capabilities to streamline the drug development process.

Strengths

  • The Accelerator™ Drug Development service offers comprehensive end-to-end solutions, which streamline the drug development process for clients.

  • Thermo Fisher Scientific has a robust global supply network with over 60 locations, ensuring local expertise and support for clients worldwide.

  • The service combines CDMO and CRO capabilities, providing a seamless experience from early development to commercial manufacturing.

  • There is a strong commitment to transparency and collaboration throughout the development process, fostering trust with clients.

  • The company has extensive experience in cGMP manufacturing, which is critical for compliance in the pharmaceutical industry.

  • Advanced digital enablement tools are integrated into the service, enhancing efficiency and visibility in the drug development journey.

  • The focus on partnership and collaboration positions the service as a strategic ally for pharmaceutical and biotech companies.

  • Patheon’s involvement in the growing trend towards outsourcing in the pharmaceutical industry indicates a strong market position and potential for increased demand.

Weaknesses

Sign in to access Weaknesses

This content is available to registered users.

Sign in

Opportunities

Sign in to access Opportunities

This content is available to registered users.

Sign in

Threats

Sign in to access Threats

This content is available to registered users.

Sign in